Operationalize: Expanded Access Programs Summit | Speakers

2024 Speakers

Akash Srivastava

Senior Manager, Medical Affairs Operations

Biogen

Anne Cropp

Chief Scientific Officer

Early Access Care

Annie Drelles

Director & Head, Office of Medical Access

Daiichi Sankyo, Inc.

Benjamin Rotz

Associate Vice President, Global Medical Policy Strategy & Operations

Eli Lilly & Co.

Cassandra Slader

Global Head of Managed Access Programs

UCB

Catherine Lawrence

Senior Medical Advisor - Mitchondrial & Neuromuscular Disorders

Santhera Pharmaceuticals

Christopher Robertson

Professor of Health Law, Policy, & Management

Boston University

Claire Wardell

Director, Managed Access

GSK

Danielle Rafferty

Associate Director, Medical Operations

Biogen

David Stein

Director, Medical Operations

Regeneron Pharmaceuticals Inc

Dennis Akkaya

Chief Commercial Officer

myTomorrows

Donna Cowan

Associate Director, Expanded Access Programs & Registry

Stealth Biotherapeutics

Elif Oral

Professor - Department of Internal Medicine, Division of Metabolism Endocrinology and Diabetes (MEND)

University of Michigan Health System

Fiona Smythe

Chief Executive Officer

MedaSystems

Florence Barkats

Patient Advocacy Lead & Digital Consultant

NHS England

Frederieke Grevers

Operational Excellence Manager

myTomorrows

Graham Sidorowicz

Chief Operating Officer

Bionical Emas

Harpreet Ram

President

EVR Consulting

Ildiko Csiki

Chief Medical & Strategy Officer

Riboscience

Jasmina Ahrens

Global Lead, Rare Humanitarian Operations

Sanofi

Jeff Waldron

Executive Director

Sherborn Consulting

Joanie Shea

Director Medical Affairs

Day One Biopharmaceuticals Inc.

Julia Peterson

Manager of Process & Systems

Sanofi

Karlijn Doorn

Head of Operations

myTomorrows

Kate Nycz

Patient Advocate

Her ALS Story

Katie Bowen

Expanded Access Coordinator

GSK

Maggie McDermott

Senior Specialist, Global Medical Operations

Regeneron Pharmaceuticals Inc

Mallory Fredericks

Associate Director, Medical Research & Value Demonstration

SpringWorks Therapeutics

Margaret Radford

Unlicensed Services Manager

Almac Group

Mark Bainbridge

Senior Director, Business Development & Early Access

Early Access Inceptua Group

Paul Stanton

Senior Director, Global Strategy

Early Access Inceptua Group

Rachel Harrison

Pre-Approval Access Program Lead, Global Medical Affairs

argenx

Ramona Reichenbach

Head Managed Access Center of Excellence

Novartis AG

Robert Mitchell-Thain

Chief Executive Officer

The PBC Foundation

Ruth Rostron

Director of EAP Program Management

Durbin Plc.

Stephanie ferket

Director

Alexion AstraZeneca Rare Disease

Stephanie petrone

clinical consultant

Consultant for GSK Oncology

Wyndi Phillips

Vice President, Project Management

WEP Clinical

2024 Event Guide